Malignant Melanoma with Concurrent BRAF E586K and NRAS Q81K Mutations

Publisher： Karger

E-ISSN： 1662-6575|7|2|297-300

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.7, Iss.2, 2014-05, pp. : 297-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma

By  

CANCER, Vol. 119, Iss. 21, 2013-11 ,pp. : 3821-3829

John Wiley & Sons Inc

Access to resources Recommend Favorite

BRAF,KIT and NRAS mutations and expression of c‐KIT, phosphorylated extracellular signal‐regulated kinase and phosphorylated AKT in Japanese melanoma patients

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 5, 2015-05 ,pp. : 477-484

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evidence for BRAF V600E and H3F3A K27M double mutations in paediatric glial and glioneuronal tumours

By  

NEUROPATHOLOGY & APPLIED NEUROBIOLOGY, Vol. 41, Iss. 3, 2015-04 ,pp. : 403-408

John Wiley & Sons Inc

Access to resources Recommend Favorite

BRAF,NRAS and MC1R status in a prospective series of primary cutaneous melanoma

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 4, 2015-04 ,pp. : 1128-1131

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic and predictive values of oncogenic BRAF, NRAS, c‐KIT and MITF in cutaneous and mucous melanoma

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 8, 2015-08 ,pp. : 1530-1538

John Wiley & Sons Inc

Access to resources Recommend Favorite